eBulletin Newsletter
NCCN Flash Updates: NCCN Guidelines Updated for Acute Myeloid Leukemia
NCCN has published updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), and the Drugs and Biologics Compendium (NCCN Compendium®) for Acute Myeloid Leukemia. These NCCN Guidelines® are currently available as Version 2.2022.
Link directly to the Updates section of the NCCN Guidelines: Acute Myeloid Leukemia
AML-6
- IDH1 or IDH2 Treatment Induction, preferred regimen added: Ivosidenib once daily (500mg) PO and azacitidine 75 mg/m2 SC or IV (days 1-7 or day 1-5, 8-9 of each 28-day cycle) (category 1) (IDH1 only)
AML-6A
- Footnote added: This regimen is approved for newly-diagnosed AML with an IDH1 mutation who met at least one of the following criteria: age >75 years, baseline ECOG performance status of ≤ 2, severe cardiac or pulmonary disease, hepatic impairment with bilirubin > 1.5 times the upper limit of normal, creatinine clearance < 45 mL/min, or other comorbidity. Montesinos P, et al. N Engl J Med 2022;386:1519-1531.
For the complete updated versions of the NCCN Guidelines, NCCN Guidelines with NCCN Evidence Blocks™, the NCCN Drugs & Biologics Compendium (NCCN Compendium®), the NCCN Biomarkers Compendium®, the NCCN Chemotherapy Order Templates (NCCN Templates®), the NCCN Radiation Therapy Compendium™, and the NCCN Imaging Appropriate Use Criteria (NCCN Imaging AUC™), please visit NCCN.org.
To view the NCCN Guidelines for Patients®, please visit NCCN.org/patientguidelines.
Free NCCN Guidelines apps for iPhone, iPad, and Android devices are now available! Visit NCCN.org/apps.
About NCCN Flash Updates™
NCCN Flash Updates™ is a subscription service from NCCN that provides timely notification of updated and new information appearing in the NCCN Guidelines, the NCCN Compendium®, and other NCCN Content.
Subscribe to NCCN Flash Updates™
Please note: 1. Third Party Content. The NCCN Content may contain content (such as figures, tables or illustrations) that NCCN licenses from third parties as displayed on NCCN Third Party Content FTP site: ftp://ftp1.nccn.org (To access: user name:content; password is NCCNcontent) (“Third Party Content”). Licensee shall be solely responsible for obtaining permissions from each such third party to use any such Third Party Content in the Permitted Works.
Access information on permissions and licensing of NCCN Content
Users may unsubscribe from Flash Updates at any time by contacting us. NOTE: The subscription fee for NCCN Flash Updates™ is non-refundable.